MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin

Dai B(Huazhong University of Science and Technology), Chen Chen(Tongji Hospital)
Cardiovascular Diabetology
September 4, 2018
10.1186/s12933-018-0767-z
Cited by 97

Related Papers

MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis
|Journal of Experimental & Clinical Cancer Research|2020|139
Selective Inhibitors of CYP2J2 Related to Terfenadine Exhibit Strong Activity against Human Cancers in Vitro and in Vivo
|Journal of Pharmacology and Experimental Therapeutics|2009|108
Extracellular vesicles remodel tumor environment for cancer immunotherapy
|Molecular Cancer|2023|105
The Cell Type–Specific Functions of miR-21 in Cardiovascular Diseases
|Frontiers in Genetics|2020|74
The role of miR-320 in glucose and lipid metabolism disorder-associated diseases
|International Journal of Biological Sciences|2020|66